These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32829196)

  • 1. Linking peripheral IL-6, IL-1β and hypocretin-1 with cognitive impairment from major depression.
    Jin K; Lu J; Yu Z; Shen Z; Li H; Mou T; Xu Y; Huang M
    J Affect Disord; 2020 Dec; 277():204-211. PubMed ID: 32829196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and characteristics of MCCB cognitive impairment in unmedicated patients with bipolar II depression and major depressive disorder.
    Lai S; Zhong S; Wang Y; Zhang Y; Xue Y; Zhao H; Ran H; Yan S; Luo Y; He J; Zhu Y; Lv S; Song Z; Miao H; Hu Y; Huang X; Lu X; Zhou J; Jia Y
    J Affect Disord; 2022 Aug; 310():369-376. PubMed ID: 35504401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation analysis of monocyte chemoattractant protein-1 and clinical characteristics and cognitive impairment in type 2 diabetes mellitus comorbid major depressive disorder.
    Cao F; Yang M; Cheng Y; Zhang X; Shi L; Li N
    Front Aging Neurosci; 2023; 15():1081393. PubMed ID: 37213540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder.
    Tian H; Li G; Xu G; Liu J; Wan X; Zhang J; Xie S; Cheng J; Gao S
    Eur Arch Psychiatry Clin Neurosci; 2021 Apr; 271(3):475-485. PubMed ID: 32361811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YY1 (Yin-Yang 1), a transcription factor regulating systemic inflammation, is involved in cognitive impairment of depression.
    Lu J; Jin K; Jiao J; Liu R; Mou T; Chen B; Zhang Z; Jiang C; Zhao H; Wang Z; Zhou R; Huang M
    Psychiatry Clin Neurosci; 2023 Mar; 77(3):149-159. PubMed ID: 36436207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Sertraline on Serum Cytokine Levels in Adolescents With First-Episode Major Depressive Disorder].
    Xiang JJ; Hong S; Ran LY; Zeng Q; Kong YT; Zhang CY; Liao J; Kuang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):310-315. PubMed ID: 36949691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between inflammatory cytokines and symptoms of major depressive disorder in adults.
    Min X; Wang G; Cui Y; Meng P; Hu X; Liu S; Wang Y
    Front Immunol; 2023; 14():1110775. PubMed ID: 36860860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder.
    Liu L; Yang X; Yang C; Tian Y; Li W; Xia L; Liu H
    J Affect Disord; 2024 Apr; 350():110-117. PubMed ID: 38220096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiome Composition Linked to Inflammatory Factors and Cognitive Functions in First-Episode, Drug-Naive Major Depressive Disorder Patients.
    Liu P; Gao M; Liu Z; Zhang Y; Tu H; Lei L; Wu P; Zhang A; Yang C; Li G; Sun N; Zhang K
    Front Neurosci; 2021; 15():800764. PubMed ID: 35153660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Plasma Levels of Mature Brain-Derived Neurotrophic Factor in Major Depressive Disorder Patients with Higher Suicidal Ideation.
    Li H; Zhao M; Jiang C; Zhao H; Wu C; Li Y; Zhang S; Xu P; Mou T; Xu Y; Huang M
    Brain Sci; 2023 Aug; 13(8):. PubMed ID: 37626579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study.
    Yang KC; Liu MN; Liou YJ; Hu LY; Yang BH; Chou YH
    J Psychiatr Res; 2021 Mar; 135():174-180. PubMed ID: 33493946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Hypocretin (Orexin) Plasma Level in Depression, Bipolar Disorder Patients.
    Li H; Lu J; Li S; Huang B; Shi G; Mou T; Xu Y
    Front Psychiatry; 2021; 12():676336. PubMed ID: 34135789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood trauma and the plasma levels of IL-6, TNF-α are risk factors for major depressive disorder and schizophrenia in adolescents: A cross-sectional and case-control study.
    Li Y; Jinxiang T; Shu Y; Yadong P; Ying L; Meng Y; Ping Z; Xiao H; Yixiao F
    J Affect Disord; 2022 May; 305():227-232. PubMed ID: 35151670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of cognitive impairment and related risk factors in patients with major depressive disorder: A case-control study.
    Wang M; Yin D; Liu L; Zhou S; Liu Q; Tian H; Wei J; Zhang K; Wang G; Chen Q; Zhu G; Wang X; Si T; Yu X; Lv X; Zhang N
    J Affect Disord; 2022 Jun; 307():29-36. PubMed ID: 35358550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum calcium levels and neuropsychological performance in depression and matched healthy controls: Reversal of correlation a marker of the aging cognitive clock?
    Grützner TM; Listunova L; Fabian GA; Kramer BA; Flach D; Weisbrod M; Roesch-Ely D; Sharma A
    Psychoneuroendocrinology; 2018 May; 91():198-205. PubMed ID: 29587243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
    Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study on Maresin-1 and cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
    Qiu T; Li X; Chen W; He J; Shi L; Zhou C; Zheng A; Lei Z; Tang C; Yu Q; Du L; Guo J
    Front Psychiatry; 2023; 14():1132791. PubMed ID: 37009097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder.
    Wang M; Wei J; Yang X; Ni P; Wang Y; Zhao L; Deng W; Guo W; Wang Q; Li T; Ma X
    Neuropsychiatr Dis Treat; 2019; 15():1695-1700. PubMed ID: 31417262
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between increased serum interleukin-6 levels and sustained attention deficits in patients with major depressive disorder.
    Ye G; Yin GZ; Tang Z; Fu JL; Chen J; Chen SS; Li J; Fu T; Yu X; Xu DW; Yao JK; Hui L
    Psychol Med; 2018 Nov; 48(15):2508-2514. PubMed ID: 29415791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.